Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$175.38

-3.94 (-2.20%)

, AMRX

Amneal Pharmaceuticals

$18.47

0.13 (0.71%)

10:36
07/13/18
07/13
10:36
07/13/18
10:36

Appeals court sides with Amneal in challenge of Jazz patents, Reuters says

The U.S. Court of Appeals for the Federal Circuit affirmed a series of rulings in favor of Amneal Pharmaceuticals (AMRX) that patents owned by Jazz Pharmaceuticals (JAZZ) related to its Xyrem drug are invalid because they described obvious ideas, according to Reuters. Reference Link

JAZZ

Jazz Pharmaceuticals

$175.38

-3.94 (-2.20%)

AMRX

Amneal Pharmaceuticals

$18.47

0.13 (0.71%)

  • 09

    Aug

  • 27

    Oct

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$175.38

-3.94 (-2.20%)

07/11/18
07/11/18
DOWNGRADE
Target $183

Equal Weight
Jazz Pharmaceuticals downgraded to Equal Weight after rally at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger downgraded Jazz Pharmaceuticals to Equal Weight from Overweight as a rally in the stock has brought it to a closing price on Tuesday of $180.57, which is approaching his unchanged price target of $183. He believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front.
07/11/18
07/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing valuation. 2. Jazz Pharmaceuticals (JAZZ) downgraded to Equal Weight at Morgan Stanley with analyst David Risinger saying he believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front. 3. U.S. Cellular (USM) and Telephone and Data (TDS) were downgraded to Underweight from Neutral at JPMorgan. 4. Hess Corp. (HES) downgraded to Underweight from Equal Weight at Barclays with analyst Paul Cheng saying his analysis indicates Hess trades at the "steepest premium" in the group. 5. Westlake Chemical (WLK) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov saying he expects softer demand to weigh on cyclical stocks and reduced his estimates for seven names in the Americas Chemicals space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/18
EVER
07/13/18
NO CHANGE
EVER
Outperform
Jazz Pharmaceuticals patent ruling a 'non-issue, says Evercore ISI
07/13/18
07/13/18
NO CHANGE
Target $160

Outperform
Evercore ISI says appeals court decision on Xyrem patents a 'non-issue' for Jazz
As previously reported, Evercore ISI analyst Umer Raffat called news that an appeals court found that seven Jazz Pharmaceuticals (JAZZ) patents being challenged by Amneal Pharmaceuticals (AMRX) are invalid a "non-issue," stating that his quick read of today's decision shows it all relates to the REMS patents and the core basis for patent life is the valproate patents. He said the patents that were ruled invalid "are not particularly relevant for Xyrem's patent estate" and he does not find today's ruling "of much significance." Raffat keeps an Outperform rating on Jazz shares, which are down 2% to $175.48 in morning trading.
AMRX Amneal Pharmaceuticals
$18.47

0.13 (0.71%)

05/18/18
JPMS
05/18/18
INITIATION
Target $18
JPMS
Neutral
Amneal Pharmaceuticals initiated with a Neutral at JPMorgan
JPMorgan analyst Chris Schott started Amneal Pharmaceuticals with a Neutral rating and $18 price target. The company is well positioned within the generics space, but its valuation trades at a premium to peers, Schott tells investors in a research note. He also notes the company's 2018 guidance requires a "significant step up" in EBITDA from Q1 levels based on a heavy cycle of upcoming pipeline launches.
05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/18
RILY
06/22/18
INITIATION
Target $26
RILY
Buy
Amneal Pharmaceuticals initiated with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck started Amneal Pharmaceuticals with a Buy rating and $26 price target. The merger of two niche generic companies created a new generic leader, Buck tells investors in a research note.

TODAY'S FREE FLY STORIES

SVU

Supervalu

$32.49

0.02 (0.06%)

, UNFI

United Natural Foods

$26.97

0.23 (0.86%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Hot Stocks
Supervalu stockholders approve merger with United Natural Foods »

Supervalu (SVU) announced…

SVU

Supervalu

$32.49

0.02 (0.06%)

UNFI

United Natural Foods

$26.97

0.23 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

CP

Canadian Pacific

$199.44

-6.51 (-3.16%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Hot Stocks
Canadian Pacific CEO says set up well for remainder of year and beyond »

"This quarter really…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

AKTS

Akoustis

$5.05

-0.7 (-12.17%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Syndicate
Akoustis files to sell common stock and $10M in convertible senior notes »

Akoustis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

OZK

Bank OZK

$34.93

-1.49 (-4.09%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Earnings
Bank OZK reports Q3 EPS 58c, consensus 90c »

Reports Q3 NII $220.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 29

    Oct

LLNW

Limelight Networks

$5.04

0.09 (1.82%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Earnings
Limelight Networks narrows FY18 adjusted EPS view to 14c-17c from 13c-17c »

Consensus 15c. Backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 29

    Oct

LLNW

Limelight Networks

$5.04

0.09 (1.82%)

16:02
10/18/18
10/18
16:02
10/18/18
16:02
Earnings
Limelight Networks reports Q3 adjusted EPS 3c, consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 29

    Oct

CP

Canadian Pacific

$199.39

-6.56 (-3.19%)

16:02
10/18/18
10/18
16:02
10/18/18
16:02
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CP

Canadian Pacific

$199.39

-6.56 (-3.19%)

16:01
10/18/18
10/18
16:01
10/18/18
16:01
Earnings
Canadian Pacific reports Q3 adjusted EPS C$4.12, consensus C$4.05 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SRCE

1st Source

$49.10

-0.73 (-1.47%)

16:01
10/18/18
10/18
16:01
10/18/18
16:01
Earnings
1st Source reports Q3 EPS 76c, consensus 89c »

According to Christopher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$26.74

-0.04 (-0.15%)

, LPNT

LifePoint

$64.53

-0.13 (-0.20%)

16:00
10/18/18
10/18
16:00
10/18/18
16:00
Hot Stocks
Trump says he is in 'total support' of people with pre-existing conditions »

President Donald Trump…

THC

Tenet

$26.74

-0.04 (-0.15%)

LPNT

LifePoint

$64.53

-0.13 (-0.20%)

HCA

HCA Healthcare

$136.43

0.01 (0.01%)

CYH

Community Health

$2.95

0.06 (2.08%)

UHS

Universal Health

$126.23

0.59 (0.47%)

CI

Cigna

$212.50

1.24 (0.59%)

HNT

Health Net

$0.00

(0.00%)

CNC

Centene

$145.91

0.54 (0.37%)

MOH

Molina Healthcare

$142.79

-0.42 (-0.29%)

AET

Aetna

$201.83

0.55 (0.27%)

UNH

UnitedHealth

$266.28

-0.95 (-0.36%)

HUM

Humana

$331.88

3.95 (1.20%)

WCG

WellCare

$318.04

1.79 (0.57%)

ANTM

Anthem

$280.98

1.4 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 14

    Dec

GS

Goldman Sachs

$224.80

-3.41 (-1.49%)

15:59
10/18/18
10/18
15:59
10/18/18
15:59
Hot Stocks
Goldman Sachs pulls out of Saudi Arabia investment conference »

When asked about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BKD

Brookdale Senior Living

$8.93

0.175 (2.00%)

15:58
10/18/18
10/18
15:58
10/18/18
15:58
Hot Stocks
Brookdale Senior Living cancels from Credit Suisse conference, Bloomberg says »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

, TEVA

Teva

$21.25

0.06 (0.28%)

15:51
10/18/18
10/18
15:51
10/18/18
15:51
Hot Stocks
Corcept slides after Teva gets tentative approval for generic version of Korlym »

An ANDA submitted by Teva…

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

TEVA

Teva

$21.25

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

GBT

Global Blood Therapeutics

$38.20

2.42 (6.76%)

15:48
10/18/18
10/18
15:48
10/18/18
15:48
Recommendations
Global Blood Therapeutics analyst commentary  »

Piper Jaffray says FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

ADP

ADP

$142.68

-1.02 (-0.71%)

15:45
10/18/18
10/18
15:45
10/18/18
15:45
Options
ADP call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

XOMA

Xoma

$14.38

-1.65 (-10.29%)

, NVS

Novartis

$86.17

0.83 (0.97%)

15:40
10/18/18
10/18
15:40
10/18/18
15:40
Hot Stocks
Breaking Hot Stocks news story on Xoma, Novartis »

Xoma drops 15% after…

XOMA

Xoma

$14.38

-1.65 (-10.29%)

NVS

Novartis

$86.17

0.83 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

XOMA

Xoma

$14.38

-1.65 (-10.29%)

15:39
10/18/18
10/18
15:39
10/18/18
15:39
Hot Stocks
Xoma says Novartis disclosed CRL received from FDA for canakinumab »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWBK

Hawthorn Bancshares

$23.65

(0.00%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Hot Stocks
Hawthorn Bancshares to sell Branson, MO branch »

Hawthorn Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$70.82

1.45 (2.09%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ISRG

Intuitive Surgical

$523.21

-19.64 (-3.62%)

15:34
10/18/18
10/18
15:34
10/18/18
15:34
Options
Intuitive Surgical options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CMCSA

Comcast

$36.11

-0.28 (-0.77%)

15:32
10/18/18
10/18
15:32
10/18/18
15:32
Hot Stocks
Comcast says it is now the largest provider of Gigabit Internet »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PTLA

Portola Pharmaceuticals

$22.02

-1.65 (-6.97%)

15:21
10/18/18
10/18
15:21
10/18/18
15:21
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

ETFC

E-Trade

$48.86

-1.71 (-3.38%)

15:19
10/18/18
10/18
15:19
10/18/18
15:19
Options
E Trade options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/18/18
10/18
15:17
10/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/18/18
10/18
15:16
10/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.